Literature DB >> 25008566

Silencing survivin activates autophagy as an alternative survival pathway in HCC cells.

Yu-Jia Chang1, Li-Tzu Li, Hsin-An Chen, Chin-Sheng Hung, Po-Li Wei.   

Abstract

Autophagy is a survival mechanism that is activated in response to nutrient deprivation. The link between aberrant autophagy and cancer has been increasingly recognized. Survivin, an anti-apoptotic molecule, and the autophagy pathway are correlated with therapeutic responses to cancer. However, the role of autophagy in cancer progression remains unclear. Here, we generated survivin knockdown cells (survivin-KD) by introducing a short interfering RNA (siRNA) into hepatocellular carcinoma (HCC) cells, and we observed a 20 % reduction in the survival of these survivin-KD cells, as determined by MTT assay. In addition, an increased number of stress granules, increased positive staining by acridine orange and a shift in the high side scatter (SSC) cell population in flow cytometry analysis were observed in survivin-KD cells. Furthermore, electron microscopy revealed an increased number of autophagosomes in survivin-KD cells compared with scrambled control cells. Finally, we treated cells with an autophagy inhibitor, 3-MA, and observed a decrease in cell survival in survivin-KD cells compared with scrambled control cells. Our study suggests that an autophagy signal may be activated after the anti-apoptotic molecule survivin is suppressed. This finding implies that autophagy may be an alternative survival pathway in HCC cells and may provide a basis for the development of new therapeutic strategies for HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008566     DOI: 10.1007/s13277-014-2257-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.

Authors:  Cheng-Jeng Tai; Hung Chin-Sheng; Li-Jen Kuo; Po-Li Wei; Hsuan-Hsuan Lu; Hsin-An Chen; Tsan-Zon Liu; Jun-Jen Liu; Der-Zen Liu; Yuan-Soon Ho; Chih-Hsiung Wu; Yu-Jia Chang
Journal:  Ann Surg Oncol       Date:  2011-04-23       Impact factor: 5.344

Review 2.  Autophagy in mammalian development and differentiation.

Authors:  Noboru Mizushima; Beth Levine
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

3.  Postresection prognosis of patients with hepatocellular carcinoma.

Authors:  A Sugioka; T Tsuzuki; T Kanai
Journal:  Surgery       Date:  1993-06       Impact factor: 3.982

4.  Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.

Authors:  Hui-Wen Chiu; Jing-Hua Lin; Yi-An Chen; Sheng-Yow Ho; Ying-Jan Wang
Journal:  Autophagy       Date:  2010-04-11       Impact factor: 16.016

5.  Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells.

Authors:  Chin-Sheng Hung; Hui-Hsiung Liu; Ming-Te Huang; Chao-Wen Cheng; Li-Jen Kuo; Yuan-Soon Ho; Chih-Hsiung Wu; Chien-Ming Chen; Po-Li Wei; Yu-Jia Chang
Journal:  Ann Surg Oncol       Date:  2012-06-19       Impact factor: 5.344

6.  Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma.

Authors:  Yu-Jia Chang; Chong-Chi Chiu; Chih-Hsiung Wu; Jane An; Cheng-Chia Wu; Tsan-Zon Liu; Po-Li Wei; Ming-Te Huang
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344

7.  Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.

Authors:  Takao Kanzawa; Yasuko Kondo; Hideaki Ito; Seiji Kondo; Isabelle Germano
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.

Authors:  K J Paquet; P Koussouris; M A Mercado; J F Kalk; D Müting; W Rambach
Journal:  Br J Surg       Date:  1991-04       Impact factor: 6.939

Review 9.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer.

Authors:  E C LaCasse; S Baird; R G Korneluk; A E MacKenzie
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

10.  Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission.

Authors:  Stefanie Sowinski; Clare Jolly; Otto Berninghausen; Marco A Purbhoo; Anne Chauveau; Karsten Köhler; Stephane Oddos; Philipp Eissmann; Frances M Brodsky; Colin Hopkins; Björn Onfelt; Quentin Sattentau; Daniel M Davis
Journal:  Nat Cell Biol       Date:  2008-01-13       Impact factor: 28.824

View more
  9 in total

1.  Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.

Authors:  Bin Wang; JiaQing Fang; Lei Qu; Zhongwei Cao; JianGuo Zhou; Biao Deng
Journal:  Tumour Biol       Date:  2015-04-08

2.  Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro.

Authors:  G Karpel-Massler; M-A Westhoff; R E Kast; A Dwucet; S Karpel-Massler; L Nonnenmacher; M D Siegelin; C R Wirtz; K-M Debatin; M-E Halatsch
Journal:  Neurochem Res       Date:  2017-03-07       Impact factor: 3.996

3.  Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2015-01-25

4.  Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma.

Authors:  Chien-Yu Huang; Uyanga Batzorig; Wan-Li Cheng; Ming-Te Huang; Wei- Yu Chen; Po-Li Wei; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2015-10-22

Review 5.  Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma.

Authors:  Yiting Qiao; Yunxin Pei; Miao Luo; Muthukumar Rajasekaran; Kam M Hui; Jianxiang Chen
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

6.  An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients.

Authors:  Peng Lin; Rong-Quan He; Yi-Wu Dang; Dong-Yue Wen; Jie Ma; Yun He; Gang Chen; Hong Yang
Journal:  Oncotarget       Date:  2018-01-09

7.  Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway.

Authors:  Po-Li Wei; Jang-Chun Lin; Chin-Sheng Hung; Precious Takondwa Makondi; Uyanga Batzorig; Tung-Cheng Chang; Chien-Yu Huang; Yu-Jia Chang
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

8.  Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma.

Authors:  Yiming Luo; Furong Liu; Shenqi Han; Yongqiang Qi; Xinsheng Hu; Chenyang Zhou; Huifang Liang; Zhiwei Zhang
Journal:  Front Mol Biosci       Date:  2021-05-20

9.  Elucidating respective functions of two domains BIR and C-helix of human IAP survivin for precise targeted regulating mitotic cycle, apoptosis and autophagy of cancer cells.

Authors:  Fabiao Hu; Daxia Pan; Wenyun Zheng; Ting Yan; Xiujuan He; Fuzheng Ren; Yiming Lu; Xingyuan Ma
Journal:  Oncotarget       Date:  2017-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.